Giant cell tumour of bone: new treatments in development

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1699-3055

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Giant cell tumour of bone: new treatments in development ; volume:17 ; number:6 ; day:24 ; month:1 ; year:2015 ; pages:419-430 ; date:6.2015
Clinical and translational oncology ; 17, Heft 6 (24.1.2015), 419-430, 6.2015

Classification: Medizin, Gesundheit

Creator: López-Pousa, A.
Broto, J. Martín
Garrido, T.
Vázquez, J.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s12094-014-1268-5

URN: urn:nbn:de:101:1-2019061002312286261804

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

López-Pousa, A.
Broto, J. Martín
Garrido, T.
Vázquez, J.
SpringerLink (Online service)

Other Objects (12)

A Case of Giant Cell Tumour of Bone in a Dog

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

Giant solitary fibrous tumour of the liver

Intracranial giant cell tumour—a case report

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case

$The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone$

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone

Metabolism in the Tumour-Bone Microenvironment

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour

Electrical stimulation in bone tissue engineering treatments

Quality Improvement Guidelines for Bone Tumour Management

A Case of Giant Cell Tumour of Bone in a Dog

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

Giant solitary fibrous tumour of the liver

Intracranial giant cell tumour—a case report

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case

$The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone$

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone

Metabolism in the Tumour-Bone Microenvironment

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour

Electrical stimulation in bone tissue engineering treatments

Quality Improvement Guidelines for Bone Tumour Management

A Case of Giant Cell Tumour of Bone in a Dog

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

Giant solitary fibrous tumour of the liver

Intracranial giant cell tumour—a case report

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case

$The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone$

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone

Metabolism in the Tumour-Bone Microenvironment

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour

Electrical stimulation in bone tissue engineering treatments

Quality Improvement Guidelines for Bone Tumour Management

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Giant cell tumour of bone: new treatments in development

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A Case of Giant Cell Tumour of Bone in a Dog

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

Giant solitary fibrous tumour of the liver

Intracranial giant cell tumour—a case report

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone

Metabolism in the Tumour-Bone Microenvironment

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour

Electrical stimulation in bone tissue engineering treatments

Quality Improvement Guidelines for Bone Tumour Management

A Case of Giant Cell Tumour of Bone in a Dog

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

Giant solitary fibrous tumour of the liver

Intracranial giant cell tumour—a case report

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone

Metabolism in the Tumour-Bone Microenvironment

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour

Electrical stimulation in bone tissue engineering treatments

Quality Improvement Guidelines for Bone Tumour Management

A Case of Giant Cell Tumour of Bone in a Dog

Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

Giant solitary fibrous tumour of the liver

Intracranial giant cell tumour—a case report

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case

The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone

Metabolism in the Tumour-Bone Microenvironment

Pleomorphic liposarcoma of bone: a rare primary malignant bone tumour

Electrical stimulation in bone tissue engineering treatments

Quality Improvement Guidelines for Bone Tumour Management

Related objects

Reset password